Company: BLNE
Filing Date: 2025-09-12
Form Type: DRS
Source: 0001493152-25-013186
Chunk: 16

Company: Beeline Holdings, Inc.
Filing Date: 2025-09-12
Form: DRS
Chunk 16
---
 cannot obtain a grace period or otherwise take the necessary actions and obtain the required approvals to effect a reverse split before a bid price deficiency occurs. If the Company’s common stock is delisted it would negatively impact the Company’s ability to raise capital and negatively impact our stockholders’ ability to trade their common stock.

| 10 |

<div align='center'>THE PURCHASE AGREEMENT</div>

Overview

On December 31, 2024, we entered into the Purchase Agreement with the Selling Stockholder, as amended and restated on March 7, 2025, pursuant to which the Selling Stockholder has agreed to purchase from us up to $10,000,000 of our common stock (subject to certain limitations). Also on December 31, 2024, we entered into a Registration Rights Agreement, as amended and restated on March 7, 2025, with the Selling Stockholder, pursuant to which we agreed to file a registration statement with the SEC to register the Selling Stockholder’s resale of shares of common stock issuable by us pursuant to the Purchase Agreement. In addition, pursuant to the Purchase Agreement, we issued C/M 573,925 shares of Series G Convertible Preferred Stock (“Series G”), (representing commitment shares valued at 1.5% of the original maximum ELOC amount), which were registered under the Form S-3. We initially used our Form S-3 under which the Selling Stockholder sold $7,500,000 of our common stock.

On September 8, 2025, we amended the Purchase Agreement to increase the commitment amount by $10,000,000. As a result, we may now sell up to $12,500,000 under the Purchase Agreement (after giving effect to prior sales). The Purchase Agreement provides that, upon the terms and subject to the conditions set forth in the Purchase Agreement, the Company may issue and sell to C/M, and C/M shall purchase from the Company, up to $12,500,000, subject to certain limitations including the Selling Stockholder’s 4.99% beneficial ownership limitation.

The Purchase Agreement and the sale of up to $20,000,000 of shares of common stock thereunder was approved by the Company’s stockholders at a special meeting on March 7, 2025.

The Purchase Agreement essentially gives us the right to put (or offer to sell) common stock to C/M as described below. Specifically, the purchase and sale terms provided for by the Purchase Agreement are summarized